Breast cancer sufferers demand answers from PHARMAC, New Zealand

Breast cancer sufferers demand answers from PHARMAC, New Zealand

8 cancer survivors are in the New Zealand High Court to fight their case against drug funding agency PHARMAC. The women are challenging PHARMAC's decision not to fund 12 months of Herceptin treatment for NZ women with HER2 positive breast cancer.

Herceptin Heroines spokesperson, Chris Walsh, said, "The lives of thousands of New Zealanders depend on the decisions PHARMAC makes. We're becoming increasingly concerned about the processes PHARMAC follows and the lack of clarity and transparency around its decision making.

"We have undertaken a Judicial Review because we are concerned about how PHARMAC managed the advice it received about Herceptin, the evidence it reviewed, and how its actions stacked up against its obligations as a crown entity.

"Internationally PHARMAC is out on a limb, on its own with this one. 24 other OECD countries now fund the proven and recommended Herceptin treatment regime of 12 months. We think it's time PHARMAC was asked to explain why it won't give us the same.

"The odd thing is, PHARMAC is so uncomfortable about the decision, that it has taken the unusual step of funding a clinical trial to prove it was right. Our argument is that New Zealanders should be receiving 52 weeks treatment until 9 weeks is shown to be an effective alternative.

"There are a large number of new, targeted therapies on the horizon and it is our belief that the issues, delays and inconsistencies seen with Herceptin simply can't be allowed to happen again with a different treatment, or another group of patients."

Walsh said oncologists know the 12 month regime provides the best chance for women to beat this type of cancer. Sadly, they can only offer 9 weeks and advise women to take 12 months if they can afford it.

Ms Walsh said many women are taking the 9 weeks offered and then fundraising to pay for as many extra treatments as they can. Others do not have resources to fundraise.

"Unfortunately, taking a government agency to court isn't cheap and we're constantly trying to find funds to continue fighting on behalf of women with breast cancer, as well as New Zealanders who could find themselves in a similar position in the future."

To help raise funds for their court battle, the Herceptin Heroines are holding a special fundraising dinner in Auckland on February 23. Celebrity and breast cancer survivor Jools Topp will be the MC. More information on the Herceptin Heroines, the Judicial Review and the gala dinner can be found online at www.breastcancer.org.nz.


(Editor compiled and published Breast cancer sufferers demand answers from PHARMAC, New Zealand at HealthNewsTrack on February 12, 2008 sourced from Breast Cancer Research Trust - http://bcrt.co.nz/)

Breast cancer - recent articles and current news stories:

- New blood test predicts breast cancer risk
- Mammography screening for breast cancer needs individualized approach
- Yoga improves quality of life in breast cancer women
- Yoga can lower fatigue inflammation in breast cancer survivors
- Computer algorithm may predict breast cancer type

Most related articles:

- Breast cancer sufferers demand answers from PHARMAC, New Zealand
- New Zealand Cancer Society's sunscreen fails - 5.6
- New risk factor for developing breast cancer - 5.6
- Women with BRCA mutation most likely to undergo mastectomy - 5.4
- Breast cancer drug Tykerb to be subsidised - 5.3

More related articles:

- Breast cancer, Herceptin, Cancer, HER2 positive breast cancer
- Inform Dual ISH to determine HER2 gene in breast cancer patients - 19.4
- Herceptin with chemotherapy improves breast cancer survival - 19.3
- HER growth proteins do not predict outcome of herceptin treatment breast cancer patients - 18.7
- SPOT-Light HER2 CISH kit approved for breast cancer patients - 17.8
- Math may predict Herceptin response in breast cancer patients - 15.2

Breast cancer related articles:

- Breast cancer drug Tykerb to be subsidised - 5.3
- Breastfeeding mothers reduce breast cancer risk - 5
- Breast cancer recurrence high in women with dense breasts - 4.9
- 7% breast cancer patients have breast reconstruction surgery - 4.8
- Exercise reduces breast cancer risk - 4.8

Breast cancer article/news source:

Read more health articles from Breast Cancer Research Trust and health articles from USA.

Breast cancer - search related terms:

Breast cancer, Cancer, HER2 positive breast cancer, Herceptin,

Mission
Health Newstrack is dedicated to serve recent and updated health & medical research, events/news, views/reviews to its subscribers and free access to general public, health & medical professionals, and other health seekers worldwide online with a user-friendly system.
Subscribe: rss | email

Top sections:
Health (188)
Breast cancer (168)
Healthcare (134)
HIV (129)
Obesity (126)
Pregnancy (114)
Diabetes (101)
Swine Flu (97)
Prostate Cancer (86)
Heart disease (84)
Smoking (81)
Alzheimer's Disease (79)
Cancer (75)
Depression (61)
Autism (52)


Current news
Herceptin Heroines are back in the High Court today to continue their case against drug funding agency PHARMAC, New Zealand.

What is Breast cancer?
About Breast cancer -- Breast cancer is the abnormal growth and uncontrolled division of cells in the breast. Cancer cells invade and destroy surrounding normal tissue, and can spread throughout the body via blood or lymph fluid (clear fluid bathing body cells) to start a new cancer in another part of the body.


List health news, Health organizations, Health news world, Glossary     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2014 HealthNewstrack.com
0.38